| Project/Area Number |
22K13423
|
|---|
| Research Category |
Grant-in-Aid for Early-Career Scientists
|
| Allocation Type | Multi-year Fund |
|---|
| Review Section |
Basic Section 07050:Public economics and labor economics-related
|
|---|
| Research Institution | Waseda University |
|---|
Principal Investigator |
富 蓉 早稲田大学, 商学学術院, 准教授 (70805259)
|
|---|
| Project Period (FY) |
2022-04-01 – 2026-03-31
|
| Project Status |
Granted (Fiscal Year 2023)
|
| Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2025: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2024: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2023: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2022: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | generic drugs |
|---|
| Outline of Research at the Start |
we aim to assess if the incentives influence physicians' and pharmacies' willingness to prescribe and dispense generics. Furthermore, we expect to determine (2) whether the policies encouraged physicians to prescribe generics; (3) whether the policies motivated pharmacists to dispense generics.
|
| Outline of Annual Research Achievements |
In 2023, we investigated the importance of the interplay between physician, pharmacist, and patient in generic drug use. We aim to contribute to the existing literature by exploring several key questions: Does a closer affiliation between hospitals and pharmacies, namely hospital-based pharmacies, correlate with increased GE usage? Does the establishment of a robust patient-pharmacy rapport, often observed in community-based pharmacies, facilitate greater GE adoption? Furthermore, how do these relationships between hospitals, patients, and pharmacies differ based on pharmacy characteristics? Lastly, of significant importance, is there an interaction between hospital-pharmacy affiliations and patient-pharmacy associations in influencing GE adoption?
|
| Current Status of Research Progress |
Current Status of Research Progress
3: Progress in research has been slightly delayed.
Reason
The slight delay in the progress of this research project is due to a combination of unforeseen challenges. Particularly, coordinating schedules with interdisciplinary collaborators and securing ethical approvals proved more time-consuming than expected, as did refining the participant recruitment strategy.The lingering logistical impacts of the COVID-19 pandemic also moderately contributed to scheduling delays for key experimental procedures.
|
| Strategy for Future Research Activity |
To improve interdisciplinary coordination, a dedicated project coordinator has been assigned, digital collaboration tools have been implemented, and structured meetings now streamline communication. Also, we’ve adjusted our laboratory scheduling to be more flexible, identified alternative spaces to avoid bottlenecks, and maintained strict safety protocols to mitigate pandemic-related impacts.
|
